AJP - Endo Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 290: E1089-E1097, 2006. First published January 3, 2006; doi:10.1152/ajpendo.00306.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/E1089    most recent
00306.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshii, H.
Right arrow Articles by Giacca, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshii, H.
Right arrow Articles by Giacca, A.

Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux

Hidenori Yoshii,1,2 Tony K. T. Lam,1 Neehar Gupta,1 Tracy Goh,1 C. Andrew Haber,1 Hiroshi Uchino,1,2 Tony T. Y. Kim,1 Victor Z. Chong,1 Keyur Shah,1 I. George Fantus,3,1 Andrea Mari,4 Ryuzo Kawamori,2 and Adria Giacca1,3

Departments of 1Physiology and 3Medicine, University of Toronto, Toronto, Ontario, Canada; 2Department of Medicine, Juntendo University, Tokyo, Japan; and 4Institute of Systems Science and Biomedical Engineering, National Research Council, Padua, Italy

Submitted 5 July 2005 ; accepted in final form 29 December 2005

We tested the hypothesis that, due to greater hepatic free fatty acid (FFA) load, portal delivery of FFAs, as in visceral obesity, induces hyperinsulinemia and increases endogenous glucose production to a greater extent than peripheral FFA delivery. For 5 h, 10 µeq·kg–1·min–1 portal oleate (n = 6), equidose peripheral oleate (n = 5), or saline (n = 6) were given intravenously to conscious dogs infused with a combination of portal and peripheral insulin to enable calculation of hepatic insulin clearance during a pancreatic euglycemic clamp. Peripheral FFAs were similar with both oleate treatments and were threefold greater than in controls. Portal FFAs were 1.5- to 2-fold greater with portal than with peripheral oleate. Peripheral insulin concentrations were greatest with portal oleate, intermediate with peripheral oleate (P < 0.001 vs. portal oleate or controls), and lowest in controls, consistent with corresponding reductions in plasma insulin clearance and hepatic insulin clearance. Although endogenous glucose production did not differ between the two routes of oleate delivery, total glucose output (endogenous glucose production plus glucose cycling) was greater with portal than with peripheral oleate (P < 0.001) despite the higher insulin levels. In conclusion, during euglycemic clamps in dogs, the main effect of short-term elevation in portal FFA is to generate peripheral hyperinsulinemia. This may, in the long term, contribute to the metabolic and cardiovascular risk of visceral obesity.

insulin resistance; hepatic glucose production; visceral obesity



Address for reprint requests and other correspondence: A. Giacca, Dept. of Physiology, Univ. of Toronto, Medical Sciences Bldg., Rm. 3336, Toronto, ON M5S1A8 Canada (e-mail: adria.giacca{at}utoronto.ca)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
I. R Hsu, S. P Kim, M. Kabir, and R. N Bergman
Metabolic syndrome, hyperinsulinemia, and cancer
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 867S - 871S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.